Dexamethasone Should NOT Be Given After 37 Weeks of Gestation
The administration of antenatal corticosteroids, including dexamethasone, is explicitly recommended AGAINST in pregnancies at or beyond 37 weeks gestation. 1
The Critical Gestational Window: 34 0/7 to 36 6/7 Weeks Only
The evidence-based recommendation is clear and specific:
Corticosteroids are indicated ONLY between 34 0/7 and 36 6/7 weeks of gestation (the "late preterm period") in women at high risk of delivery within 7 days and before 37 weeks 1
After 37 weeks (term gestation), corticosteroids for fetal lung maturity are NOT recommended (GRADE 1B recommendation) 1
Why This Distinction Matters
The Late Preterm Evidence (34-36 Weeks)
The landmark ALPS trial demonstrated clear benefits when steroids are given in the late preterm period:
- 20% reduction in need for respiratory support (11.6% vs 14.4%, RR 0.80) 1
- 33% reduction in severe respiratory morbidity (8.1% vs 12.1%, RR 0.67) 1
Why NOT After 37 Weeks
At term gestation (≥37 weeks), fetal lungs are already mature. The risk-benefit ratio shifts unfavorably because:
- No demonstrated benefit: Babies born at term have naturally mature lungs and do not require pharmacologic acceleration of lung maturation
- Potential harms without benefit: Exposure to corticosteroids carries risks (neonatal hypoglycemia, uncertain long-term neurodevelopmental effects) without the offsetting respiratory benefits seen in preterm infants 1
- Low likelihood of benefit: The guideline explicitly states to avoid steroids when there is "low likelihood of delivery before 37 weeks" 1
The Specific Clinical Algorithm
Give betamethasone (NOT dexamethasone as first-line) when ALL criteria are met:
- Singleton pregnancy
- Gestational age between 34 0/7 and 36 6/7 weeks
- High probability of delivery within next 7 days
- Delivery expected BEFORE 37 weeks
- No pregestational diabetes mellitus 1
Do NOT give corticosteroids when:
- Gestational age is ≥37 weeks
- Low likelihood of delivery before 37 weeks 1
Important Caveats
Elective Cesarean at Term
While one meta-analysis 2 suggested potential benefit for term cesarean deliveries, this contradicts the high-quality SMFM guideline recommendations. The guideline evidence takes precedence: avoid routine use at term given uncertain long-term risks and lack of established benefit 1.
The Diabetes Contraindication
Corticosteroids are contraindicated in women with pregestational diabetes even in the late preterm period (GRADE 1C), due to significantly increased risk of severe neonatal hypoglycemia 1. This risk would be even more problematic at term when the respiratory benefits are absent.
Long-term Safety Concerns
The guidelines explicitly acknowledge that long-term neurodevelopmental risks remain uncertain 1. This uncertainty further supports restricting use to situations with proven short-term benefit (late preterm period only), not extending to term pregnancies where benefit is unproven.
Bottom Line
The question contains a fundamental misconception: dexamethasone (or any antenatal corticosteroid) should NOT be given after 37 weeks. The evidence-based window is strictly 34 0/7 to 36 6/7 weeks in high-risk patients expected to deliver before term. At or beyond 37 weeks, fetal lungs are mature, the treatment offers no proven benefit, and potential harms exist without offsetting advantages.